Skip to main content
. 2024 May 31;5(1):e383. doi: 10.1002/deo2.383

TABLE 1.

Patient characteristics.

UCSEMS
n = 32
Age, median (range), years 79 (59–90)
Sex, male, n (%) 21 (65.6)
Primary disease, n (%)
Bile duct cancer 18 (56.3)
Gallbladder cancer 1 (3.1)
Other cancers 14 (43.8)
Hepatocellular carcinoma 2 (6.3)
Gastric cancer 1 (3.1)
Malignant Lymphoma 1 (3.1)
Lymph node metastasis 9 (28.1)
Pancreatic duct dilation, n (%) 0
Post‐cholecystectomy, n (%) 2 (6.3)
Tumor involvement at the orifice of the cystic duct, n (%) 11 (34.4)
Cholangitis before stent placement, n (%) 17 (53.1)
Chemotherapy after stent placement, n (%) 10 (31.2)
Complete response 0
Partial response 2
Stable disease 2
Progressive disease 6

Abbreviation: UCSEMS, uncovered self‐expandable metallic stent.